Barrett Esophagus  >>  dexlansoprazole  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dexlansoprazole / Generic mfg.
NCT02162758: Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation

Terminated
2
6
US
Dexlansoprazole, Dexilant, Dexlansoprazole Placebo
Takeda
Barrett's Esophagus
04/16
04/16

Download Options